Vaccination and contraception were key issues in the pharmacy sector this week
Vaccination made headlines, with the announcement that Moderna is to be the vaccine supplied by community pharmacies in Stage 3 of the COVID-19 vaccination program. We also looked at research led by Dr Sandra Salter from the University of Western Australia which showed that people accessing vaccines at pharmacies reported fewer adverse events compared with other settings including general practice.
The Federal Government gave the go-ahead to several pharmacy trials, including those looking at osteoporosis and kidney disease: but the announcement wasn’t without controversy. One of the trials, the ALLIANCE trial out of Monash which aims to see pharmacists discussing contraceptive options with patients seeking emergency contraception, saw a backlash from the public… with Dr Safeera Hussainy from Monash and SPHERE telling the AJP that she was shocked at the way it was reported in the mainstream media.
The AMA spoke out about its submission on downscheduling the oral contraceptive pill, criticising pharmacies as “retail shops” where it is inappropriate to discuss sexual health—a view refuted by the Pharmacy Guild‘s Anthony Tassone. Chemist Warehouse partnered with Gotcha4Life to raise awareness and funds for men’s health.
Friends of Science in Medicine‘s Dr Ken Harvey and Professor John Dwyer criticised the TGA in MJA InSight for approving Caruso’s Prostate EZE Max for an AUST L(A) listing. A report developed by the Consumers Health Forum of Australia on behalf of NPS MedicineWise looked at consumer health literacy.
Congratulations to Associate Professor Faye McMillan, Donald Burge and Brenley Milsom, who were all recognised in this year’s Queen’s Birthday Honours List. And congratulations also to the winners of our Pharmacy’s Got Talent contest… find out who won here!